Innoviva, Inc. (INVA)
20.50
-0.05
(-0.24%)
USD |
NASDAQ |
Oct 02, 16:00
20.51
+0.01
(+0.05%)
After-Hours: 20:00
Innoviva Market Cap : 1.489B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.489B |
| October 01, 2026 | 1.493B |
| September 30, 2026 | 1.541B |
| September 29, 2026 | 1.533B |
| September 28, 2026 | 1.542B |
| September 25, 2026 | 1.506B |
| September 24, 2026 | 1.501B |
| September 23, 2026 | 1.470B |
| September 22, 2026 | 1.524B |
| September 21, 2026 | 1.528B |
| September 18, 2026 | 1.536B |
| September 17, 2026 | 1.529B |
| September 16, 2026 | 1.540B |
| September 15, 2026 | 1.514B |
| September 14, 2026 | 1.518B |
| September 11, 2026 | 1.501B |
| September 10, 2026 | 1.498B |
| September 09, 2026 | 1.535B |
| September 08, 2026 | 1.550B |
| September 04, 2026 | 1.549B |
| September 03, 2026 | 1.551B |
| September 02, 2026 | 1.551B |
| September 01, 2026 | 1.531B |
| August 31, 2026 | 1.509B |
| August 28, 2026 | 1.523B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.522B |
| August 26, 2026 | 1.543B |
| August 25, 2026 | 1.538B |
| August 24, 2026 | 1.528B |
| August 21, 2026 | 1.530B |
| August 20, 2026 | 1.525B |
| August 19, 2026 | 1.560B |
| August 18, 2026 | 1.544B |
| August 17, 2026 | 1.522B |
| August 14, 2026 | 1.539B |
| August 13, 2026 | 1.507B |
| August 12, 2026 | 1.512B |
| August 11, 2026 | 1.507B |
| August 10, 2026 | 1.502B |
| August 07, 2026 | 1.490B |
| August 06, 2026 | 1.533B |
| August 05, 2026 | 1.490B |
| August 04, 2026 | 1.515B |
| August 03, 2026 | 1.533B |
| July 31, 2026 | 1.548B |
| July 30, 2026 | 1.566B |
| July 29, 2026 | 1.597B |
| July 28, 2026 | 1.610B |
| July 27, 2026 | 1.572B |
| July 24, 2026 | 1.582B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zevra Therapeutics, Inc. | 592.83M |
| Collegium Pharmaceutical, Inc. | 715.61M |
| ANI Pharmaceuticals, Inc. | 1.658B |
| Corcept Therapeutics, Inc. | 12.54B |
| Veru, Inc. | 42.80M |
Market Cap Related Metrics
| PE Ratio | 4.994 |
| PS Ratio | 3.710 |
| PEG Ratio | 0.0044 |
| Price to Book Value | 1.207 |
| Price to Free Cash Flow | 8.887 |
| Price | 20.50 |
| Earnings Yield | 20.02% |
| PEGY Ratio | 0.0044 |
| Operating PE Ratio | 10.36 |
| Normalized PE Ratio | 8.966 |